Stock Events

Stock Events

Nxera Pharma. 

$5.28
7
-$0.29-5.21% Monday 20:00

Statistics

Day High
5.6
Day Low
5.54
52W High
7.2
52W Low
4.9
Volume
1,200
Avg. Volume
39
Mkt Cap
477.82M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 15
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

8MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.55
-0.21
0.13
0.47
Expected EPS
N/A
Actual EPS
N/A

Financials

-16.91%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
379.99MRevenue
-64.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SOLTF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a major player in the pharmaceutical industry, directly competing in various therapeutic areas covered by Nxera Pharma.
Merck
MRK
Mkt Cap214.76B
Merck operates globally in the pharmaceutical sector, offering products that compete with Nxera Pharma's range, especially in prescription drugs.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson offers a broad range of health products that compete across multiple segments, including those targeted by Nxera Pharma.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes in the pharmaceutical and healthcare sectors, with overlapping interests in medications and therapies.
Novartis
NVS
Mkt Cap237.61B
Novartis is known for its extensive research and development in pharmaceuticals, competing with Nxera Pharma in innovation and market share.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the global pharmaceutical market, particularly in areas of chronic diseases, directly challenging Nxera Pharma's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb is a key competitor in the pharmaceutical industry, with a strong presence in drug development and marketing.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates internationally, offering products that compete in the same therapeutic areas as Nxera Pharma.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is a major pharmaceutical company with competitive products in the diabetes and cancer sectors, relevant to Nxera Pharma's interests.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global competitor, particularly in the generic pharmaceuticals market, impacting Nxera Pharma's market dynamics.

About

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Christopher Cargill
Employees
387
Country
JP
ISIN
JP3431300007

Listings

TSE
JP
4565.TSE
OTC Link
US
SOLTF
F
DE
JSS.F

0 Comments

Share your thoughts

FAQ

What is Nxera Pharma. stock price today?▼
The current price of SOLTF is $5.28 USD — it has decreased by -5.21% in the past 24 hours. Watch Nxera Pharma. stock price performance more closely on the chart.
What is Nxera Pharma. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nxera Pharma. stocks are traded under the ticker SOLTF.
Is Nxera Pharma. stock price growing?▼
SOLTF stock has fallen by -5.21% compared to the previous week, the month change is a -2.94% fall, over the last year Nxera Pharma. has showed a -10.66% decrease.
What is Nxera Pharma. market cap?▼
Today Nxera Pharma. has the market capitalization of 477.82M
When is the next Nxera Pharma. earnings date?▼
Nxera Pharma. is going to release the next earnings report on May 08, 2026.
What were Nxera Pharma. earnings last quarter?▼
SOLTF earnings for the last quarter are -0.55 USD per share, whereas the estimation was 0.47 USD resulting in a -215.68% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nxera Pharma. revenue for the last year?▼
Nxera Pharma. revenue for the last year amounts to 379.99M USD.
What is Nxera Pharma. net income for the last year?▼
SOLTF net income for the last year is -64.26M USD.
Does Nxera Pharma. pay dividends?▼
Yes, SOLTF dividends are paid en. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Nxera Pharma. have?▼
As of April 03, 2026, the company has 387 employees.
In which sector is Nxera Pharma. located?▼
Nxera Pharma. operates in the Health Care sector.
When did Nxera Pharma. complete a stock split?▼
The last stock split for Nxera Pharma. was on June 27, 2018 with a ratio of 4:1.
Where is Nxera Pharma. headquartered?▼
Nxera Pharma. is headquartered in Minato, JP.